Adesto to Participate at the Benchmark Discovery Conference on December 4 Nasdaq:IOTS


(MENAFN- GlobeNewsWire - Nasdaq) SANTA CLARA, Calif., Nov.20, 2019(GLOBE NEWSWIRE) --Adesto Technologies Corporation(NASDAQ: IOTS), a leading provider of innovative application-specific semiconductors and embedded systems for the IoT, today announced that Ron Shelton, chief financial officer, will participate at the Benchmark Discovery One-on-One Conference to be held at the New York Athletic Club on Wednesday, December 4, 2019. Management will be available to meet with investors throughout the day.

Portfolio managers and analysts who would like to request a meeting with management should contact their Benchmark Company representative or email: .

About Adesto Technologies Corp.
Adesto Technologies Corporation (NASDAQ: IOTS) is a leading provider of innovative application-specific semiconductors and embedded systems for the IoT. The company's technology is used by more than 5,000 customers worldwide who are creating differentiated solutions across industrial, consumer, medical and communications markets. With its growing portfolio of high-value technologies, Adesto is helping its customers usher in the era of the Internet of Things. See:www.adestotech.com . Follow Adesto onTwitter .

Adesto and the Adesto logo are trademarks or registered trademarks of Adesto Technologies Corporation or its subsidiaries in the United States and other countries. Other company, product, and service names may be trademarks or service marks of others.

Adesto Media Contact:
Jen Bernier-Santarini
+1 650-336-4222

Adesto Investor Relations:
Leanne K. Sievers
Shelton Group
+1-949-224-3874


MENAFN2011201900703653ID1099302580


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.